Follow the BioPorto A/S stock price and the full insider trade history of the company, a publicly traded company based in Denmark. Shares are listed on the DK market, under the supervision of Finanstilsynet DK. Operating in the Health Care sector, BioPorto A/S has logged 40 reports. Market capitalisation: €596.6m. The latest transaction was disclosed on 24 November 2025 (Subscription). The full history is openly available.
40
Insider Decl.
n/a
Thresholds
€46m
12 ops.
Buy Volume
€6m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioPorto A/S Strong Buy (bullish), based on 1 analysts. Average price target: DKK 1.75.
41Σ signal
Buys €46m€6m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,724 of 28,958 companies
29.3
score / 100
Value
14
Quality
45
FCF yld-13%
Earn yld-14%
EV/EBITDA·
ROE-126%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioPorto A/S is a Danish company specializing in the development of medical diagnostics. It focuses on innovative tests for serious diseases, particularly kidney disorders.